MEP39308A - Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method - Google Patents
Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such methodInfo
- Publication number
- MEP39308A MEP39308A MEP-393/08A MEP39308A MEP39308A ME P39308 A MEP39308 A ME P39308A ME P39308 A MEP39308 A ME P39308A ME P39308 A MEP39308 A ME P39308A
- Authority
- ME
- Montenegro
- Prior art keywords
- substance
- subcutaneous dose
- fsh
- substances
- amount equivalent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Pregnancy & Childbirth (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02077221 | 2002-06-07 | ||
PCT/NL2003/000370 WO2003103770A2 (en) | 2002-06-07 | 2003-06-06 | Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method |
Publications (1)
Publication Number | Publication Date |
---|---|
MEP39308A true MEP39308A (en) | 2011-02-10 |
Family
ID=29724462
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MEP-393/08A MEP39308A (en) | 2002-06-07 | 2003-06-06 | Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method |
Country Status (21)
Country | Link |
---|---|
US (1) | US7815912B2 (ja) |
EP (1) | EP1511537B1 (ja) |
JP (1) | JP2005530818A (ja) |
KR (1) | KR20050058285A (ja) |
CN (1) | CN1684737A (ja) |
AU (1) | AU2003274929B2 (ja) |
BR (1) | BR0305033A (ja) |
CA (1) | CA2488719A1 (ja) |
EA (1) | EA009371B1 (ja) |
ES (1) | ES2399962T3 (ja) |
IL (1) | IL165522A0 (ja) |
IS (1) | IS7586A (ja) |
ME (1) | MEP39308A (ja) |
MX (1) | MXPA04012246A (ja) |
NO (1) | NO20045304L (ja) |
NZ (1) | NZ536984A (ja) |
PL (1) | PL373991A1 (ja) |
RS (1) | RS105004A (ja) |
UA (1) | UA81251C2 (ja) |
WO (1) | WO2003103770A2 (ja) |
ZA (1) | ZA200409857B (ja) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101583363B (zh) * | 2007-01-08 | 2013-08-21 | 潘塔希生物科学股份有限公司 | 治疗或预防雌性哺乳动物不育症的方法和此类方法中使用的药物试剂盒 |
KR20140053991A (ko) * | 2011-07-18 | 2014-05-08 | 아츠 바이올로직스 에이/에스 | 장기간 작용하는 황체 형성 호르몬 (lh) 화합물 |
US9282995B2 (en) * | 2011-12-22 | 2016-03-15 | Previvo Genetics, Llc | Recovery and processing of human embryos formed in vivo |
US20150272622A1 (en) | 2011-12-22 | 2015-10-01 | Previvo Genetics, Llc | Recovery and processing of human embryos formed in vivo |
US9216037B2 (en) | 2013-06-21 | 2015-12-22 | Previvo Genetics, Llc | Uterine lavage for embryo retrieval |
MX2019000498A (es) | 2016-07-21 | 2019-09-16 | ObsEva SA | Regímenes de dosis de antagonista de oxitocina para promover la implantación embrionaria y prevenir abortos espontaneos. |
WO2021043726A1 (en) | 2019-09-03 | 2021-03-11 | ObsEva S.A. | Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage |
EP4103750A1 (en) | 2020-02-10 | 2022-12-21 | ObsEva S.A. | Biomarkers for oxytocin receptor antagonist therapy |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0788799A3 (en) * | 1996-02-07 | 1998-10-21 | ASTA Medica Aktiengesellschaft | LHRH-Antagonists in the treatment of fertility disorders |
CN1199642A (zh) * | 1997-05-16 | 1998-11-25 | Asta药物股份公司 | 治疗不育症的lhrh-拮抗剂 |
EP0994718B1 (en) * | 1997-06-20 | 2005-08-17 | Akzo Nobel N.V. | Gonadotropin releasing hormone antagonist |
AU752415B2 (en) | 1998-04-23 | 2002-09-19 | Zentaris Ivf Gmbh | Method for the treatment of fertility disorders |
BR0008468A (pt) * | 1999-02-24 | 2002-02-05 | Novo Nordisk As | Método para fertilização humana in vitro, uso de um hormÈnio hipotalânico e/ou hormÈnio pituitário ou de um agonista ou antagonista do mesmo ou de um derivado ativo do mesmo, kit farmacêutico em forma de dosagem única, e, qualquer novo aspecto ou combinação de aspectos |
CA2341974A1 (en) | 1999-06-23 | 2001-01-04 | Akzo Nobel Nv | Gonadotropin releasing hormone antagonist |
US20030092628A1 (en) * | 1999-06-23 | 2003-05-15 | De Greef Henrik Johan Matthieu Maria | Gonadotropin releasing hormone antagonist |
MEP38808A (en) * | 2001-09-12 | 2011-02-10 | Merck Serono Sa | Use of lh in controlled ovarian hyperstimulation |
EP1455831B1 (en) | 2001-12-21 | 2007-10-31 | Pantarhei Bioscience B.V. | Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method |
-
2003
- 2003-06-06 BR BR0305033-5A patent/BR0305033A/pt not_active IP Right Cessation
- 2003-06-06 CN CNA038183900A patent/CN1684737A/zh active Pending
- 2003-06-06 NZ NZ536984A patent/NZ536984A/en unknown
- 2003-06-06 MX MXPA04012246A patent/MXPA04012246A/es unknown
- 2003-06-06 US US10/517,028 patent/US7815912B2/en not_active Expired - Fee Related
- 2003-06-06 KR KR1020047019890A patent/KR20050058285A/ko not_active Application Discontinuation
- 2003-06-06 EA EA200401619A patent/EA009371B1/ru not_active IP Right Cessation
- 2003-06-06 UA UAA200500168A patent/UA81251C2/uk unknown
- 2003-06-06 CA CA002488719A patent/CA2488719A1/en not_active Abandoned
- 2003-06-06 AU AU2003274929A patent/AU2003274929B2/en not_active Ceased
- 2003-06-06 WO PCT/NL2003/000370 patent/WO2003103770A2/en active Application Filing
- 2003-06-06 JP JP2004510888A patent/JP2005530818A/ja active Pending
- 2003-06-06 ME MEP-393/08A patent/MEP39308A/xx unknown
- 2003-06-06 EP EP03741621A patent/EP1511537B1/en not_active Expired - Lifetime
- 2003-06-06 RS YUP-1050/04A patent/RS105004A/sr unknown
- 2003-06-06 ES ES03741621T patent/ES2399962T3/es not_active Expired - Lifetime
- 2003-06-06 PL PL03373991A patent/PL373991A1/xx not_active Application Discontinuation
-
2004
- 2004-12-02 IL IL16552204A patent/IL165522A0/xx unknown
- 2004-12-03 IS IS7586A patent/IS7586A/is unknown
- 2004-12-03 NO NO20045304A patent/NO20045304L/no not_active Application Discontinuation
- 2004-12-06 ZA ZA200409857A patent/ZA200409857B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200409857B (en) | 2006-02-22 |
KR20050058285A (ko) | 2005-06-16 |
EA200401619A1 (ru) | 2005-06-30 |
BR0305033A (pt) | 2004-11-09 |
AU2003274929A1 (en) | 2003-12-22 |
WO2003103770A3 (en) | 2004-04-22 |
UA81251C2 (en) | 2007-12-25 |
US20050235374A1 (en) | 2005-10-20 |
EP1511537B1 (en) | 2012-11-21 |
MXPA04012246A (es) | 2005-04-08 |
CN1684737A (zh) | 2005-10-19 |
PL373991A1 (en) | 2005-09-19 |
EA009371B1 (ru) | 2007-12-28 |
NZ536984A (en) | 2008-01-31 |
ES2399962T3 (es) | 2013-04-04 |
IL165522A0 (en) | 2006-01-15 |
EP1511537A2 (en) | 2005-03-09 |
CA2488719A1 (en) | 2003-12-18 |
RS105004A (en) | 2007-02-05 |
IS7586A (is) | 2004-12-03 |
AU2003274929B2 (en) | 2008-04-10 |
US7815912B2 (en) | 2010-10-19 |
NO20045304L (no) | 2005-02-07 |
JP2005530818A (ja) | 2005-10-13 |
WO2003103770A2 (en) | 2003-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Schneider et al. | Estradiol and the neuroendocrine control of LH release in vitro | |
ITMI941048A1 (it) | Uso di antagonisti degli oppiacei e di sali di calcio per la preparazione di medicamenti per il trattamento di forme patologiche endorfino-mediate | |
AR011217A1 (es) | UN PÉPTIDO ANTAGONISTA DE GNRH, UNA COMPOSICIoN FARMACÉUTICA PARA INHIBIR LA SECRECIoN DE GONADOTROPINAS EN MAMíFEROS Y UN COMPUESTO INTERMEDIARIO PARA PREPARAR UN PÉPTIDO ANTAGONISTA DE GNRH. | |
Huirne et al. | Effect of an oral contraceptive pill on follicular development in IVF/ICSI patients receiving a GnRH antagonist: a randomized study | |
ROSEMBERG et al. | Clinical effect of human urinary postmenopausal gonadotropin | |
MEP39308A (en) | Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method | |
RU2005136527A (ru) | Унитарная комбинация fsh и hcg | |
Reichman et al. | GnRH antagonist-based protocols for in vitro fertilization | |
Tur-Kaspa et al. | GnRH antagonist, cetrorelix, for pituitary suppression in modern, patient-friendly assisted reproductive technology | |
EA200200801A1 (ru) | Применение фолликулостимулирующего гормона (fsh) для лечения бесплодия | |
EA200400591A1 (ru) | СПОСОБ ВВЕДЕНИЯ ПЕПТИДА ТИМОЗИН α1 | |
WO2005018657A3 (en) | NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY | |
BRPI0409571A (pt) | métodos e kits para a manutenção de gravidez, tratamento de cistos foliculares, e sincronização da ovulação empregando-se hormÈnio de luteinização | |
WO2005019457A3 (en) | NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY | |
EP0474787A1 (en) | METHOD FOR TREATING STERILITY AND AGENT USED IN THE PROCESS. | |
CA2412899A1 (en) | Medicinal preparations for treating sex hormone-dependent diseases | |
Mills et al. | Is the postovulatory release of follicle-stimulating hormone in the rabbit mediated by luteinizing hormone-releasing hormone? | |
MXPA03009447A (es) | Inhibidor de aromatasa de dosis unica para tratamiento de infertilidad. | |
KR20030051828A (ko) | 에스트로겐 의존성 질환의 병용 치료법 | |
Curry | Alterations in incidence of mating and copulation-induced ovulation after olfactory bulb ablation in female rats | |
BR9611760A (pt) | Novos antagonistas lh-rh com efeito aperfeiçoado | |
Bretzlaff | Physiology and pharmacology of the postpartum cow and retained fetal membranes | |
Torres et al. | Comparison of embryo implantation in Wistar rats that underwent ovarian stimulation using exogenous gonadotropins associated with cetrorelix acetate or leuprolide acetate | |
Tarhan et al. | Oxytocin-induced contractions of the rabbit corpus cavernosum | |
Felberbaum et al. | Entwicklung und Anwendung der GnRH-Analoga in der Sterilitätstherapie |